Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Trans Fats Bad for the Memory

A new study reports that greater consumption of dietary trans fatty acids (dTFA) is strongly linked to worsening memory in men aged 45 and older, compared to men who consume no dTFA.

Omega-3s and Alzheimer's Risk

Consuming more omega-3 fatty acids may benefit some patients at risk for Alzheimer's disease.

Placebo Effect in Marijuana-Dementia Study?

Low-dose oral tetrahydrocannabinol (THC) may not ease the common behavioral symptoms that affect people with dementia

Seizure Drug Boosts MS Patient Eyesight

New research suggests that a medication indicated to treat seizures could also reduce the risk of nerve damage and blindness in patients with multiple sclerosis (MS).

Air Pollution's Effects on the Brain

Long-term exposure to ambient air pollution may be linked to subtle changes in the brain that could lead to cognitive impairment, a new study suggests.

New Qudexy XR Monotherapy Age Range

The FDA has approved a Supplemental New Drug Application (sNDA) for Qudexy XR (topiramate; Upsher-Smith) extended-release capsules for monotherapy in patients ages 2 to less than 10 years old with partial onset (POS) or primary generalized tonic-clonic (PGTC) seizures.

Physicians Not Disclosing Alzheimer's Diagnosis

In a new report from the Alzheimer's Association, only 45% of patients with Alzheimer's disease or their caregivers stated that they were told the diagnosis by their physician and were more likely to be told the diagnosis after the disease had become more advanced.

News

Diazepam Sold Online May Actually Be Antipsychotic, FDA Warns

The Food and Drug Administration (FDA) issued a warning about the potential risk of purchasing counterfeit diazepam online.

Vitamin D Shows Negative Association With ALS Progression

Mechanisms underlying the relationship between vitamin D and ALS still unknown

Investigational MS Tx Reduces Relapse Rate in Trials

Genentech announce positive results from two Phase 3 studies evaluating ocrelizumab compared with Rebif (interferon beta-1a) in patients with relapsing multiple sclerosis (MS).

Eteplirsen NDA Submission Completed for Duchenne Muscular Dystrophy

Sarepta Therapeutics announced that it has completed a rolling submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA) for eteplirsen.

FEATURES

Neurological Complications Caused by "Skinny Jeans"

Neurological Complications Caused by "Skinny Jeans"

So-called "skinny jeans" (slim-fitting jeans tapered at the ankle) are a fashion statement to many but could also be a health risk when combined with excess squatting, according to a case report published online in the Journal of Neurology, Neurosurgery & Psychiatry.

Prescription Drug Interaction with Ginseng Leads to DRESS Syndrome

Prescription Drug Interaction with Ginseng Leads to DRESS Syndrome

A case study in Pharmacotherapy describes the first known instance of a drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome likely induced by a drug interaction between lamotrigine and ginseng.

Seizures Return After Initiating Vilazodone for MDD

Seizures Return After Initiating Vilazodone for MDD

Seizures induced by selective serotonin reuptake inhibitor (SSRI) use are rare and are more likely to be linked to larger doses and severe symptoms (such as those present in serotonin syndrome), but a new case study in the journal Pharmacotherapy described a patient that developed seizures after vilazodone treatment was initiated.

Featured courses from mycme

Sleeplessness Bad for the HeartExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Study Questions Statin, Memory Loss ConnectionExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Untreated Sleep Apnea Boosts Risk of Heart Disease, StrokeExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters